Fundraising Fox

Pulmonx Corp.

NASDAQ: LUNG

San Jose, US · Delaware corporation · 4 known investors

pulmonx.com

Pulmonx develops the Zephyr Valve, a bronchoscopic medical device for treating severe COPD and emphysema without surgery. The device targets patients with severe lung disease requiring minimally invasive intervention.

HealthtechMedical Devicesin /pulmonx@my_lungs

Founders & leadership

GE
GLENDON E. FRENCHExecutive Officer, Director
DG
DANA G. MEAD, JRDirector
SS
RP
RODNEY PERKINS, M.D.Director
OS
OERN STUGEDirector
MM
MICHAEL MATLYDirector
LC
LAUREN CRISTINAExecutive Officer
RF
RICH FERRARIDirector

Investors · 4

Reported raises · per SEC filings

Form D private placements
$65.1MraisedApr 2019 · 18 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • STAFFAN LINDSTRANDDirector
  • LAUREN CRISTINAExecutive Officer
  • GLENDON E. FRENCHExecutive Officer, Director
  • RICH FERRARIDirector
  • MICHAEL MATLYDirector
  • STEPHEN SALMONDirector
  • DANA G. MEAD, JRDirector
  • CHARLES CHONDirector
  • OERN STUGEDirector
  • RODNEY PERKINS, M.D.Director
Offering amount
$65.1M
Amount sold
$65.1M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$50MraisedApr 2017 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • GLENDON E. FRENCHExecutive Officer, Director
  • DANA G. MEAD, JRDirector
  • STEPHEN SALMONDirector
  • RODNEY PERKINS, M.D.Director
  • OERN STUGEDirector
  • MICHAEL MATLYDirector
  • LAUREN CRISTINAExecutive Officer
  • STAFFAN LINDSTRANDDirector
  • RICH FERRARIDirector
Offering amount
$50M
Amount sold
$50M
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news